QR kód

Early non-invasive ventilation and high-flow nasal oxygen therapy for preventing endotracheal intubation in hypoxemic blunt chest trauma patients: the OptiTHO randomized trial

Abstract Background The benefit–risk ratio of prophylactic non-invasive ventilation (NIV) and high-flow nasal oxygen therapy (HFNC-O2) during the early stage of blunt chest trauma remains controversial because of limited data. The main objective of this study was to compare the rate of endotracheal...

Celý popis

Uloženo v:
Hlavní autoři: Cédric Carrié, Benjamin Rieu, Antoine Benard, Kilian Trin, Laurent Petit, Alexandre Massri, Igor Jurcison, Guillaume Rousseau, David Tran Van, Marie Reynaud Salard, Jeremy Bourenne, Albrice Levrat, Laurent Muller, Damien Marie, Claire Dahyot-Fizelier, Julien Pottecher, Jean-Stéphane David, Thomas Godet, Matthieu Biais
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2023-04-01
Edice:Critical Care
Témata:
Chest trauma
Respiratory failure
Non-invasive ventilation
High-flow nasal oxygen therapy
Intensive care
On-line přístup:https://doi.org/10.1186/s13054-023-04429-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky